Abstract
Introduction
Coronary heart disease is one of the leading causes of death worldwide. The recent advances in percutaneous coronary interventions (PCI), the lower rates of complications, and the continuously increasing availability of this approach have considerably reduced the number of patients referred for coronary artery bypass grafting (CABG) over the past decades (1) . However, not all novel PCI-related approaches have met our expectations; bioresorbable scaffolds have been associated with very late stent thrombosis (2) and coronary aneurysm formation (3) , whereas the safety of ticagrelor, one of the novel promising antiplatelet agents, and its benefit on mortality, stent thrombosis, and myocardial infarction have been significantly challenged (4) . Furthermore, in patients with multivessel and left main disease, CABG continues to represent the gold standard (5) .
Although post-CABG morbi-mortality has significantly declined over the past years, in-hospital mortality remains >2% and complications continue to occur in up to one-third of patients (1) . Many of these complications have been linked to patients' preoperative risk profile. However, the immediate postoperative course of this population is also dependent on intraoperative factors; extracorporeal circulation (ECC) and total surgery time have been linked to adverse in-hospital outcomes in previous studies (6, 7) .
The very early inflammatory surge that follows CABG surgery has been incriminated in the occurrence of many post-CABG complications (8) . Accumulating data indicate that higher magnitude of this very early CABG-related inflammatory response is associated with poorer short-and long-term outcomes (9) , whereas administration of serine protease inhibitors has been associated with reduced post-CABG morbidity (10) . However, it remains unclear how much of the inflammatory response that occurs in the very early post-CABG phase reflects the amount of trauma caused by the surgical procedure per se and how much of it is actually due to concomitant confounding factors such as the administration of protamine, of blood and/ or blood products, complement system activation by the contact of blood with the surface of the extracorporeal circuit and exposure of blood to abnormal shear forces, or to acute lesions due to electrical defibrillation. The dynamics of the systemic inflammatory response to CABG beyond the very early postoperative phase and its relevance to clinical outcomes are not fully understood.
Accordingly, we aimed to assess whether the previously reported impact of the duration of CABG on postoperative inflammatory marker levels is maintained beyond the very early post-CABG phase and to investigate whether the magnitude of this post-CABG inflammatory response contributes to patients' in-hospital postoperative outcomes.
Material and methods

Study population
Thirty consecutive patients treated by elective CABG in our center between March 2016 and June 2017 were studied prospectively. All patients were admitted to hospital for a firsttime elective CABG procedure, were ≥18 years of age and were hemodynamically stable at the moment of inclusion. Patients were not included in the study if concomitant valve replacement or other intervention was planned to be performed within the same procedure, if they had systemic inflammatory diseases, or if they were on ongoing steroids or other anti-inflammatory drugs except for low doses of aspirin. All patients underwent surgery involving median sternotomy and standard ECC. Patients gave written informed consent; the research protocol complied with the Declaration of Helsinki and was approved by the local Ethics Committee.
Age, gender, data regarding concomitant cardiovascular conditions (i.e., arterial hypertension, diabetes mellitus) and ongoing drug therapy were recorded for each patient. Left ventricular ejection fraction (LVEF) assessed by transthoracic echocardiography and the SYNergy between PCI with TAXUS™ and Cardiac Surgery (SYNTAX I) score were also recorded. For each patient, the duration of ECC, of aortic clamping, and the total duration of the CABG procedure were recorded.
Inflammatory status assessment before and after coronary artery bypass grafting Venous blood samples were collected from each patient one day prior to CABG. Two additional venous blood samples were collected on days 2 and 5 after the procedure.
White blood cell (WBC) count was performed using the direct current detection method (Sysmex XP-300 Automated Hematology Analyzer; Sysmex Corporation, Japan). High-sensitivity C-reactive protein (hs-CRP) was determined by the immunoturbidimetric method (Automated Analyzer Cobas Integra 400; Roche Diagnostics), as described previously (11) . Interleukins 1b (IL-1b), 2 (IL-2), 6 (IL-6), and 8 (IL-8) were quantified with bead-based Multiplex assays using the xMAP Luminex technology (Flexmap 3D analyzer; Luminex Corporation, Austin, TX).
Post-coronary artery bypass grafting in-hospital outcomes
Patients were prospectively monitored for clinically relevant post-CABG complications up to the time of discharge. Length of hospital stay was recorded. Prolonged hemodynamic instability, the occurrence of death, stroke, respiratory dysfunction, and in-hospital kidney and/ or liver dysfunction were recorded as major complications. Patients were considered to have prolonged hemodynamic instability if they required inotropic or vasopressor therapy for more than 24 hours after the procedure. Kidney dysfunction was defined as an increase in plasma creatinine ≥0.5 mg/dL, whereas liver dysfunction was defined as a ≥3-fold increase in liver transaminases. Other post-CABG complications, including surgical wound infection and post-CABG hemorrhage, were also noted.
Statistical analysis
Continuous variables are expressed as means ± standard error of mean or, when skewed, median and interquartile range (IQR). Categorical data are presented using absolute numbers and percentages. The paired t-test or the Wilcoxon matched-pairs signed-ranks test were applied for comparison of inflammatory markers level at different time points. Spearman's rank correlation method or Pearson's correlation method were used to assess correlations between CABG-related parameters (i.e., durations of ECC, aortic clamping, and total CABG duration) and inflammatory markers levels, as well as between inflammatory markers levels and post-CABG in-hospital complications. Stepwise logistic regression analysis was used to assess the ability of post-CABG inflammatory markers levels to independently predict post-CABG in-hospital complications. The models were adjusted for age, history of arterial hypertension, and diabetes mellitus. All tests were two-sided and a p-value < 0.05 was considered statistically significant. All data were computed using MedCalc for Windows, version 12.4.3.0 (MedCalc Software, Ostend, Belgium).
Results
Baseline characteristics of the study population Out of the 30 patients included in this prospective study (80% male; mean age 60.1 ± 9.6 years), 29 patients (96.7%) had a history of arte-rial hypertension and 11 patients (36.7%) were diabetics. On admission, 27 patients (90.0%) were receiving statins, 24 (80.0%) were receiving angiotensin-converting enzyme inhibitors and/ or angiotensin II receptor blockers, 2 (6.7%) were on antialdosteronics, and 27 (90.0%) were on beta-blocker therapy. Median LVEF on admission was 50% (IQR 45-55) and SYNTAX I score was 24.8 ± 1.7 points.
Coronary artery bypass grafting surgery times and postoperative inflammatory status Overall, the total duration of CABG was 252.3 ± 62.3 min. Patients were in ECC for 104.5 ± 38.8 min, and aortic clamping time was 58.7 ± 21.9 min.
Inflammatory marker levels prior to CABG, and 2 and 5 days after CABG are presented in Figure 1 . As expected, CABG was associated with a significant increase in all studied inflammatory marker levels. For most evaluated inflammatory markers, peak levels were recorded in postoperative day 2. Whereas plasma levels of IL-1b, IL-2, and IL-8 remained relatively constant (all p >0.05 compared to postoperative day 2), WBC count, hs-CRP, and IL-6 levels significantly decreased by postoperative day 5 (all p< 0.01 compared to postoperative day 2). However, on postoperative day 5, WBC count, hs-CRP, and IL-6 levels continued to be significantly higher than prior to CABG surgery (all p< 0.0001). In addition, day 2 post-CABG hs-CRP (rho = 0.34, p< 0.0001), IL-6 (rho = 0.39, p< 0.0001), and IL-8 (rho = 0.50, p< 0.0001) levels significantly positively correlated with baseline, preoperative hs-CRP, IL-6, and IL-8 levels, respectively. hsCRP -high-sensitivity C reactive protein; IL -interleukin; WBC -white blood cells Data are expressed as means ± standard error of the mean.
There was no significant correlation between ECC, aortic clamping, or total surgery times and post-CABG WBC count, hs-CRP, IL-1b, or IL-2 levels (all p >0.05). However, peak IL-8 levels ( Figure 2 Peak inflammatory marker levels and in-hospital post-coronary artery bypass grafting complications None of the study patients died during hospital stay and no patient required an intraaortic balloon pump during the perioperative period. Median length of hospital stay was 13 (IQR 11-18) days. Of the 30 patients included in the study, 22 (73%) presented at least one post-CABG complication, and 8 patients (26%) presented >1 complication. A detailed list of these complications is provided in Table 1 .
There was no significant correlation between peak WBC count and any of the post-CABG complications (all p >0.05). Peak hs-CRP levels were significantly positively correlated with the length of hospital stay (rho = 0.42, p = 0.03), whereas peak IL-1b, IL-2, and IL-6 levels sig- In multiple regression analysis including age, history of arterial hypertension and diabetes mellitus, correlations between all other inflammatory markers and post-CABG complications were lost (all p >0.05), with the exception of peak IL-8 levels, which remained a strong independent predictor of post-CABG kidney (p = 0.02) and liver (p = 0.04) dysfunction, as well as of a sum of post-CABG major complications ≥2 (p = 0.04).
Discussions
The main findings of the present study were that 1) CABG surgery was associated with marked increase in WBC count, as well as in hs-CRP, IL-1b, IL-2, IL-6, and IL-8 levels; 2) longer duration of ECC and aortic clamping caused a larger post-CABG inflammatory surge, 3) whereas the duration of total CABG surgery had a less significant effect; and 4) peak IL-8 levels independently predicted post-CABG kidney and liver dysfunction, as well as a sum of post-CABG major complications ≥2.
Longer duration of extracorporeal circulation and aortic clamping leads to a larger postoperative inflammatory surge
The pro-inflammatory effect of CABG is well-established and has been related, in addition to intrinsic myocardial trauma, to a multitude of factors including administration of protamine, of blood and/ or blood products, contact of the blood with the surface of the extracorporeal circuit and exposure of the blood to abnormal shear forces (12) . Whereas these latter factors initiate inflammation during and immediately after CABG, protracted intrinsic myocardial sufferance is likely to become more relevant later on, after the very early post-CABG phase. Although the immediate inflammatory response has been related to a multitude of very early post-CABG complications, including prolonged hemodynamic instability, hyperthermia, or bleeding disorders, most post-CABG complications such as tissue edema, fever, arrhythmias, myocardial ischemia and dysfunction, respiratory distress syndrome, renal failure, or neurologic injury, generally occur days after the procedure (13) . Meanwhile, experimental studies have demonstrated that complement system activation (13), but also IL-6 (14) and IL-8 (15) administration are followed by clinically relevant biological effects within hours and not days. Therefore, it seems reasonable to hypothesize that these relatively late complications are unlikely to be a consequence of the initial inflammatory response. Indeed, previous studies have demonstrated a biphasic pattern of tumor necrosis factor α (TNFα), IL-1b, IL-6, IL-8 (12, 16) , and complement activation (13) , characterized by an early peak within the first hours after the end of cardiopulmonary bypass, return to near normal values by 24 hours, and then a second increase 48 hours after the procedure. Although the exact origin of this ensuing inflammatory reaction has not been established, its presence may be of greater discriminatory value for higher protracted myocardial injury (17, 18) . The present study confirms that the levels of several inflammatory markers are elevated following CABG, a finding that has been reported in varying degrees by a number of previous studies (9) . Our results add to the already existing data and indicate IL-8 as one of the most adequate markers for evaluating post-CABG inflammation, not only in the very early but also in the later postoperative phase.
Previous studies have demonstrated significant correlations between the duration of ECC and the magnitude of the very early inflammatory response (9, 19, 20) . This is not surprising, given that cardiopulmonary bypass is known to induce a systemic inflammatory response and that longer ECC duration increases the likelihood of blood and/ or blood product administration and prolongs the contact of the blood with the extracorporeal circuit and its exposure to abnormal shear forces, all of which have been associated with pro-inflammatory effects (21) . However, the potential impact of ECC, aortic clamping, and/ or total surgery times on the inflammatory response beyond the very early post-CABG phase has not been assessed previously. The present study indicates for the first time that longer duration of ECC and aortic clamping is associated with higher IL-6 and IL-8 levels 48 hours after CABG surgery, whereas the duration of total CABG surgery has a less significant or even negligible effect.
The significant correlation between ECC and aortic clamping time and post-CABG IL-6 and particularly IL-8 levels, together with the weaker correlation between total surgery time and IL-8 and the lack of correlation between total surgery time and IL-6 indicate cardiopulmonary bypass, and not surgical trauma itself as one of the major factors responsible for post-CABG inflammation and suggest that avoiding cardiopulmonary bypass may be associated with less inflammation and therefore with better postoperative outcomes. Indeed, previous studies have associated off-pump CABG with better long-term survival compared with on-pump CABG (22) . However, others suggested that on-pump CABG may actually reduce in-hospital mortality, as well as late all-cause mortality compared to off-pump CABG (23, 24) . Displacement of the heart to expose the target vessels during off-pump CABG, causing hemodynamic impairment, has been proposed to explain these findings (25) . While the debate on the superiority of off-pump versus on-pump CABG still continues, it is obvious from the results of the present study that reduction of the post-CABG inflammatory surge by shortening the duration of cardiopulmonary bypass should be one of the goals of surgeons performing onpump CABG.
Peak interleukin 8 levels independently predict post-coronary artery bypass complications A number of established cardiovascular risk factors are widely accepted predictors of post-CABG complications. However, factors related to the surgical intervention itself, including the postoperative inflammatory surge, are expected to have a major impact on the postoperative course of these patients. Accordingly, after demonstrating the impact of ECC and aortic clamping time on day 2 post-CABG inflammatory markers levels, we thought to assess whether this larger inflammatory response is reflected into worse patients' clinical outcomes.
Our results show that IL-6 and particularly IL-8 levels 48 hours after elective CABG surgery correlate with the duration of inotropic or vasopressor therapy, with the occurrence of kidney and liver dysfunction, as well as with the occurrence and the sum of major post-CABG complications. However, in multivariate analysis, neither peak IL-6 nor peak IL-8 levels remained independent predictors of the duration of inotropic or vasopressor therapy or of major post-CABG complications. However, "IL-8 hyperresponders" had a greater risk of developing kidney and liver dysfunction and presented more major post-CABG complications. Thus, the present study demonstrates that elevated day 2 post-CABG IL-8 levels independently predict the later occurrence of a number of clinically relevant in-hospital complications after elective CABG procedures.
From a mechanistic point of view, these relatively late inflammatory marker levels may reflect more accurately the amount of intrinsic myocardial damage and may be less dependent on CABG-related confounding factors. Indeed, postoperative troponin T levels have been shown to correlate with early, mid-, and long-term morbi-mortality in CABG patients (18, (26) (27) (28) , and troponin T levels at 48 hours after the CABG procedure have been associated with the highest prognostic power (18, 27, 29) . Similar results have been reported for creatine kinase-myocardial band (18) . However, late assessment of inflammatory marker levels may be less useful for guiding early and intensified prophylactic strategies.
Meanwhile, our results and the results of previously published studies demonstrate that inflammation is clinically relevant following CABG and indicate IL-8 as a potential target for reducing post-CABG complications. Glucocorticoids (30), interleukin 4 (31) and/ or IL-8 receptor antagonists may all prove useful in this regard. However, to date, only limited data are available regarding the potential benefit of IL-8 pathway inhibition in cardiovascular diseases. Alternatively, the present study suggests that benefit could be obtained by simply reducing the duration of ECC and aortic clamping.
Finally, the present study demonstrated that baseline hs-CRP, IL-6, and particularly IL-8 levels were significantly correlated with day 2 postoperative levels of these markers, suggesting that baseline IL-8 levels could be used to predict "IL-8 hyperresponders" and thus to identify the population at the highest risk of post-CABG exaggerated inflammatory response and complications, who would benefit the most from reduction of cardiopulmonary bypass duration and/ or other prophylactic strategies.
Potential limitations
Our study has a number of limitations. This is a single-center, observational study and therefore cannot ascribe causality. We evaluated a relatively small and homogenous population undergoing elective on-pump CABG surgery. Thus, although our results are in line with those of previous studies, these data cannot be generalized to the entire population of patients undergoing CABG. Also, we performed a limited range of inflammatory marker measurements (preoperative, and 2 and 5 days postoperative); inflammatory marker levels during and immediately after CABG were not determined. Thus, the presence of a second inflammatory peak in postoperative day 2 was not documented in the present study and we cannot exclude the fact that inflammatory marker levels measured 48 hours after CABG reflect the natural descending progression of the initial inflammatory surge. However, previous studies have repeatedly demonstrated the presence of a second inflammatory peak, at least for TNFα, IL-1b, IL-6, IL-8, and the complement system. Above all, the present study should be viewed as a basis for future larger-scale studies.
Conclusions
This prospective study demonstrated that elective CABG surgery is associated with a significant inflammatory response. Longer duration of ECC and aortic clamping caused a larger increase in day 2 post-CABG IL-6 and IL-8 levels, whereas the duration of total CABG surgery had a less significant (for IL-8) or even negligible (for IL-6) effect. At their turn, IL-8 levels measured 48 hours after CABG independently predicted postoperative kidney and liver dysfunction, as well as a sum of major post-CABG complications ≥2. Taken together, these data suggest that targeting the IL-8 pathway using antiinflammatory agents, or simply by shortening the duration of ECC and aortic clamping, could improve the in-hospital post-CABG outcomes in this population.
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